PREDINAM

TBscore (and suPAR) used to PREDict and INtervene Against high Mortality (PREDINAM) - a randomised trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR2009110001673419

Enrollment

400

Registered

2009-11-25

Start date

2014-05-13

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS Tuberculosis Nutritional, Metabolic, Endocrine

Interventions

AFYA biscuits - nutritional supplementation (TBsuspects)

Normal treatment (TB suspects)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - adults (> 15 years) - At least one symptom indicating possible TB: 3 weeks of cough, sputum production or weight loss. - Residents or long-term guests of Bandim I, Bandim II, Belem, Mindara and Cuntum.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
gain in BMI	—

Secondary

Measure	Time frame
all-cause mortality	—

Countries

Guinea-Bisseu

Contacts

Public ContactFrauke Rudolf

MD PhD

frauke.rudolf@ki.au.dk+45 51372359

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026